Patents by Inventor Michael L. West

Michael L. West has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210272056
    Abstract: Systems, methods, and computer program products are provided for tracking one or more items. In one exemplary embodiment, there is provided a method for tracking one or more hems. The method may include periodically detecting, by a sensor device, sensor information of the one or more items, and periodically transmitting, by the sensor device, the sensor information. The method may also include determining if the one or more parties is authorized to receive the sensor information. The method may also include transmitting the sensor information to the one or more authorized parties. The method may further include determining if the one or more parties is authorized to receive the sensor information and the periodically transmitting the sensor information to the one or more authorized parties based on a set of one or more permissions that grants or restricts access of the one or more parties to the sensor information based on the set of one or more permissions.
    Type: Application
    Filed: May 18, 2021
    Publication date: September 2, 2021
    Inventors: Mark D. HAMM, James B. GREER, Daniel A. OST, Miley E. AINSWORTH, William S. MURPHY, Zachary S. PERRY, Ole Petter SKAAKSRUD, Kenneth L. MILMAN, Michael R. WEST, James Randy JACOBS
  • Publication number: 20170205427
    Abstract: Disclosed herein is a method for screening and diagnosis of Anderson-Fabry Disease in a subject based on biomarker expression in patient samples. Also disclosed are computer systems, kits, and software for implementation of the biomarkers.
    Type: Application
    Filed: July 22, 2015
    Publication date: July 20, 2017
    Inventors: Michael L. West, Gavin Oudit, Bruce M. McManus, Zsuzsanna Hollander
  • Patent number: 9243018
    Abstract: Preparation and use of synthetic monosaccharides, disaccharides, trisaccharides, tetrasaccharides and pentasaccharides useful for the preparation of synthetic heparinoids.
    Type: Grant
    Filed: January 29, 2014
    Date of Patent: January 26, 2016
    Assignee: DR. REDDY'S LABORATORIES, SA
    Inventors: Joachim Seifert, Latika Singh, Tracie E. Ramsdale, Michael L. West, Nicholas B. Drinnan
  • Publication number: 20150045289
    Abstract: The present invention relates to the method of pre-preparing pharmaceutical compositions for therapeutic uses, particularly pre-preparing medications for treating patients (e.g., cancer patients and the like) by intravenous infusion.
    Type: Application
    Filed: July 14, 2014
    Publication date: February 12, 2015
    Inventors: MICHAEL L. WEST, Tracey J. BROWN
  • Publication number: 20150005485
    Abstract: Preparation and use of synthetic monosaccharides, disaccharides, trisaccharides, tetrasaccharides and pentasaccharides useful for the preparation of synthetic heparinoids.
    Type: Application
    Filed: January 29, 2014
    Publication date: January 1, 2015
    Applicant: ALCHEMIA LIMITED
    Inventors: Joachim SEIFERT, Latika SINGH, Tracie E. RAMSDALE, Michael L. WEST, Nicholas B. DRINNAN
  • Patent number: 8686131
    Abstract: Preparation and use of synthetic trisaccharides useful for the preparation of synthetic heparinoids.
    Type: Grant
    Filed: December 14, 2011
    Date of Patent: April 1, 2014
    Assignee: Alchemia Limited
    Inventors: Joachim Seifert, Latika Singh, Tracie E. Ramsdale, Michael L. West, Nicholas B. Drinnan
  • Patent number: 8673586
    Abstract: A method of inhibiting or effecting the activity of protein kinase activity which comprises contacting a protein kinase with a compound of formula (I) being a derivative of a furanose or pyranose form of a monosaccharide, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: May 1, 2012
    Date of Patent: March 18, 2014
    Assignee: Alchemia Limited
    Inventors: Wim Meutermans, Karl Schafer, Michael L. West, Craig Muldoon, Fiona Foley, Natalie Bouloc, Gerald Tometzki
  • Patent number: 8426345
    Abstract: The invention provides a method of identifying biologically active compounds comprising: (a) designing a first library of compounds of formula (1) to scan molecular diversity wherein each compound of the library has at least two pharmacophoric groups R1 to R5 as defined below and wherein compound of the library has same number of pharmacophoric groups; (b) assaying the first library of compounds in one or more biological assay(s); and (c) designing a second library wherein each compound of the second library contains one or more additional pharmacophoric group with respect to the first library; such that the/each component of the first and second library is a compound of formula (1).
    Type: Grant
    Filed: October 3, 2006
    Date of Patent: April 23, 2013
    Assignee: Alchemia Limited
    Inventors: Wim Meutermans, Johannes Zuegg, Michael L. West
  • Patent number: 8404833
    Abstract: Preparation and use of synthetic disaccharides useful for the preparation of synthetic heparinoids.
    Type: Grant
    Filed: December 14, 2011
    Date of Patent: March 26, 2013
    Assignee: Alchemia Limited
    Inventors: Joachim Seifert, Latika Singh, Tracie E. Ramsdale, Michael L. West, Nicholas B. Drinnan
  • Publication number: 20130011852
    Abstract: A method of inhibiting or effecting the activity of protein kinase activity which comprises contacting a protein kinase with a compound of formula (I) being a derivative of a furanose or pyranose form of a monosaccharide, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 1, 2012
    Publication date: January 10, 2013
    Applicant: Alchemia Limited
    Inventors: Wim Meutermans, Karl Schafer, Michael L. West, Craig Muldoon, Fiona Foley, Natalie Bouloc, Gerald Tometzki
  • Patent number: 8114970
    Abstract: Preparation of synthetic monosaccharides, for use in the preparation of synthetic heparinoids.
    Type: Grant
    Filed: January 15, 2009
    Date of Patent: February 14, 2012
    Assignee: Alchemia Limited
    Inventors: Joachim Seifert, Latika Singh, Tracie E. Ramsdale, Michael L. West, Nicholas B. Drinnan
  • Publication number: 20110201794
    Abstract: Methods are described for the preparation of combinatorial libraries of potentially biologically active disaccharide compounds. These compounds are variously functionalized, with a view to varying lipid solubility size, function an other properties, with the particular aim of discovering novel drug or drug-like compounds, or compounds with useful properties. The invention provides intermediates, processes and synthetic strategies for the solution or solid phase synthesis of disaccharides, variously functionalized about the sugar ring, including the addition of aromaticity and charge, and the placement of pharmaceutically useful groups and isosteres.
    Type: Application
    Filed: December 17, 2010
    Publication date: August 18, 2011
    Applicant: Alchemia Limited
    Inventors: Wim Meutermans, Michael L. West, George Adamson, Giang Thanh Le, Nicholas B. Drinnan, Giovani Abbenante, Bernd Becker, Matthias Grathwohl, Premraj Rajaratnam, Gerald Tometzki
  • Publication number: 20110165700
    Abstract: A method of inhibiting or effecting the activity of an integrin receptor comprises contacting an integrin with a pyranose of formula I, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 14, 2011
    Publication date: July 7, 2011
    Applicant: Alchemia Limited
    Inventors: Wim MEUTERMANS, Michael L. West, Giang Thanh Le, Judy Halliday, Christopher Clark
  • Publication number: 20090163373
    Abstract: The invention provides a method of identifying biologically active compounds comprising: (a) designing a first library of compounds of formula (1) to scan molecular diversity wherein each compound of the library has at least two pharmacophoric groups R1 to R5 as defined below and wherein compound of the library has same number of pharmacophoric groups; (b) assaying the first library of compounds in one or more biological assay(s); and (c) designing a second library wherein each compound of the second library contains one or more additional pharmacophoric group with respect to the first library; such that the/each component of the first and second library is a compound of formula (1).
    Type: Application
    Filed: October 3, 2006
    Publication date: June 25, 2009
    Applicant: Alchemia Limited
    Inventors: Gerald B. Tometzki, Michael L. West, Wim Meutermans, Johannes Zuegg
  • Patent number: 7541445
    Abstract: Preparation of synthetic monosaccharides, disaccharides, trisaccharides, tetrasaccharides and pentasaccharides for use in the preparation of synthetic heparinoids.
    Type: Grant
    Filed: September 6, 2002
    Date of Patent: June 2, 2009
    Assignee: Alchemia Limited
    Inventors: Joachim Seifert, Latika Singh, Tracie E. Ramsdale, Michael L. West, Nicholas B. Drinnan
  • Publication number: 20090129379
    Abstract: Described are computer-based methods and apparatuses, including computer program products, for parsing, flagging, and/or reconstructing data on a network. Data packets associated with user requests are distributed among a plurality of data centers for processing. The data packets are captured at the data centers for fraud detection. The captured data packets are preprocessed at the data center. The preprocessing includes disregarding data packets that are not applicable to fraud detection. The preprocessing includes indicating if data packets are applicable to fraud detection. The indicating of the applicable data packets includes parsing the data packets using particular rules optimized for fraud detection. The data packets are processed at each data center to reconstruct part of the data associated with a user. The processing of the data packets includes reconstructing the data packets based on customer information from network information and/or cookie information.
    Type: Application
    Filed: November 21, 2007
    Publication date: May 21, 2009
    Applicant: FMR LLC
    Inventors: RICHARD COSIMO DIBIASO, SEAN STANLEY BRUMBLE, JAY MICHAEL ERICKSON, MICHAEL L. WEST, WILLIAM KENT Van VLIET, MARC THOMAS LEAVITT
  • Publication number: 20090129400
    Abstract: Described are computer-based methods and apparatuses, including computer program products, for parsing, flagging, and/or reconstructing data on a network. Data packets associated with user requests are distributed among a plurality of data centers for processing. The data packets are captured at the data centers for fraud detection. The captured data packets are preprocessed at the data center. The preprocessing includes disregarding data packets that are not applicable to fraud detection. The preprocessing includes indicating if data packets are applicable to fraud detection. The indicating of the applicable data packets includes parsing the data packets using particular rules optimized for fraud detection. The data packets are processed at each data center to reconstruct part of the data associated with a user. The processing of the data packets includes reconstructing the data packets based on customer information from network information and/or cookie information.
    Type: Application
    Filed: November 21, 2007
    Publication date: May 21, 2009
    Applicant: FMR LLC
    Inventors: RICHARD COSIMO DIBIASO, Sean Stanley Brumble, Jay Michael Erickson, Michael L. West, William Kent Van Vliet, Marc Thomas Leavitt
  • Publication number: 20080176815
    Abstract: A method of inhibiting or effecting the activity of protein kinase activity which comprises contacting a protein kinase with a compound of formula (I) being a derivative of a furanose or pyranose form of a monosaccharide, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 19, 2007
    Publication date: July 24, 2008
    Applicant: ALCHEMIA LIMITED
    Inventors: Wim Meutermans, Karl Schafer, Michael L. West, Craig Muldoon, Fiona Foley, Natalie Bouloc, Gerald Tometzki
  • Publication number: 20080176936
    Abstract: A method of inhibiting or effecting the activity of an integral receptor which comprises contacting an integrin with a compound of formula I, or a pharmaceutically acceptable salt thereof; General Formula I Wherein the ring may be of any configuration; Z is sulphur, oxygen, CH2, NH, NRA or hydrogen, in the case where Z is hydrogen then R1 is not present, RA is selected from the set defined for R1 to R5, X is oxygen or NRA providing that at least one X of General Formula I is NRA, X may also combine independently with one of R1 to R5 to form an azide, R1 to R5 are independently selected from the group comprising H, —(CO)R6 or an alkyl, acyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, arylalkyl or heteroarylalkyl substituent of 1 to 20 atoms, which is optionally substituted, and can be branched or linear wherein substituents may optionally be further substituted, wherein R6 is selected from the group comprising an alkyl, acyl, alkenyl, alkynyl, heteroalkyl, aryl, heteroaryl, arylalkyl or heteroarylalkyl s
    Type: Application
    Filed: February 2, 2006
    Publication date: July 24, 2008
    Inventors: Wim Meutermans, Michael L. West, Giang Thanh Le, Judy Halliday, Christopher Clark
  • Patent number: 7291623
    Abstract: A method of inhibiting or effecting the activity of protein kinase activity which comprises contacting a protein kinase with a compound of formula (I) being a derivative of a furanose or pyranose form of a monosaccharide, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: September 5, 2003
    Date of Patent: November 6, 2007
    Assignee: Alchemia Limited
    Inventors: Wim Meutermans, Karl Schafer, Michael L. West, Craig Muldoon, Fiona Foley, Natalie Bouloc, Gerald Tometzki